Search Results - "Qian, Qijun"

Refine Results
  1. 1

    Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor by Zhang, Zhiwei, Jiang, Duqing, Yang, Huan, He, Zhou, Liu, Xiangzhen, Qin, Wenxia, Li, Linfang, Wang, Chao, Li, Yang, Li, He, Xu, Hai, Jin, Huajun, Qian, Qijun

    Published in Cell death & disease (17-06-2019)
    “…Mesothelin (MSLN) is an attractive antigen for chimeric antigen receptor (CAR) T therapy and the epitope selection within MSLN is essential. In this study, we…”
    Get full text
    Journal Article
  2. 2

    Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy by Zhang, Yajun, Wang, Pei, Wang, Tengjiao, Fang, Yuan, Ding, Yongmei, Qian, Qijun

    Published in Journal of translational medicine (18-02-2021)
    “…Although chimeric antigen receptor (CAR)-T cell therapy has been remarkably successful for haematological malignancies, its efficacy against solid tumors is…”
    Get full text
    Journal Article
  3. 3

    An efficient Screening System in Yeast to Select a Hyperactive piggyBac Transposase for Mammalian Applications by Wen, Wen, Song, Shanshan, Han, Yuchun, Chen, Haibin, Liu, Xiangzhen, Qian, Qijun

    “…As non-viral transgenic vectors, the transposon system represents an attractive tool for gene delivery to achieve a long-term gene expression in immunotherapy…”
    Get full text
    Journal Article
  4. 4

    Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients by Ding, Min, Wang, Ying, Chi, Jiachang, Wang, Tao, Tang, Xiaoyin, Cui, Dan, Qian, Qijun, Zhai, Bo

    Published in PloS one (22-12-2016)
    “…Cellular immunotherapy has appeared to be a promising modality for the treatment of malignant tumor. The objective of this study was to evaluate the efficacy…”
    Get full text
    Journal Article
  5. 5

    Rapid response in relapsed follicular lymphoma with massive chylous ascites to anti-CD19 CAR T therapy using Piggy Bac: A case report by Zhang, Yan, Lin, Zhicai, Zhang, Faliang, Chen, Xiuxiu, Yang, Yaping, Fu, Xin, Li, Zhong, Sun, Yan, Qian, Qijun

    Published in Frontiers in immunology (01-12-2022)
    “…CD19-directed chimeric antigen receptor (CAR) T cell therapy has been shown to achieve a considerably durable response in patients with refractory or relapsed…”
    Get full text
    Journal Article
  6. 6

    Evaluation of Nonviral piggyBac and lentiviral Vector in Functions of CD19chimeric Antigen Receptor T Cells and Their Antitumor Activity for CD19 + Tumor Cells by Lin, Zhicai, Liu, Xiangzhen, Liu, Tao, Gao, Haixia, Wang, Sitong, Zhu, Xingli, Rong, Lijie, Cheng, Jingbo, Cai, Zhigang, Xu, Fu, Tan, Xue, Lv, Linjie, Li, Zhong, Sun, Yan, Qian, Qijun

    Published in Frontiers in immunology (10-01-2022)
    “…Nonviral transposon (PB) and (LV) vectors have been used to deliver chimeric antigen receptor (CAR) to T cells. To understand the differences in the effects of…”
    Get full text
    Journal Article
  7. 7

    αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib by Fang, Juemin, Ding, Na, Guo, Xinling, Sun, Yan, Zhang, Zhiwei, Xie, Bailu, Li, Zhong, Wang, Hui, Mao, Wei, Lin, Zhicai, Qin, Fei, Yuan, Min, Chu, Wenqi, Qin, Huanlong, Qian, Qijun, Xu, Qing

    Published in Journal for immunotherapy of cancer (01-02-2021)
    “…Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological malignancies in China. In particular, advanced/refractory ovarian cancer…”
    Get full text
    Journal Article
  8. 8

    Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans by Wen, Lu, Huang, Yu, Peng, Ling, Zhao, Kaiping, Sun, Yan, Lin, Zhicai, Chen, Yuanyuan, Li, Zhong, Qian, Qijun, Tong, Fan, Zhang, Ruiguang, Dong, Xiaorong

    Published in Frontiers in immunology (17-08-2022)
    “…“On-target off-tumor” toxicity is a major challenge to the use of chimeric antigen receptor (CAR)-engineered T cells in the treatment of solid malignancies,…”
    Get full text
    Journal Article
  9. 9

    PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report by Li, Chenggong, Sun, Yan, Wang, Jing, Tang, Lu, Jiang, Huiwen, Guo, Tao, Liu, Lin, Wu, Yaohui, Ai, Lisha, Xia, Linghui, Wu, Jianjun, Lin, Zhicai, Qian, Qijun, Hu, Yu, Mei, Heng

    Published in Frontiers in immunology (25-05-2021)
    “…MYC/BCL2/BCL6 triple-hit lymphoma (THL) is an uncommon subset of high-grade B-cell lymphoma with aggressive clinical behavior and poor prognosis. TP53 mutation…”
    Get full text
    Journal Article
  10. 10

    Triggered Immune Response Induced by Antigenic Epitopes Covalently Linked with Immunoadjuvant-Pulsed Dendritic Cells as a Promising Cancer Vaccine by Qian, Qijun, Han, Feng, Liu, Xiangzhen, Li, Qilong, Aldarouish, Mohanad, Chen, Chumeng, Liu, Hui

    Published in Journal of immunology research (2020)
    “…The success of peptide-based dendritic cell (DC) cancer vaccines mainly depends on the utilized peptides and selection of an appropriate adjuvant. Herein, we…”
    Get full text
    Journal Article
  11. 11

    Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia by Tong, Yin, You, Liangshun, Liu, Hui, Li, Lu, Meng, Haitao, Qian, Qijun, Qian, Wenbin

    Published in Oncotarget (01-06-2013)
    “…An attractive strategy among adenovirus-based oncolytic systems is to design adenoviral vectors to express pro-apoptotic genes, in which this gene-virotherapy…”
    Get full text
    Journal Article
  12. 12

    Therapeutic Mechanism of Nucleic Acid Drugs by Liu, Lianxiao, Gao, Haixia, Guo, Chuanxin, Liu, Tao, Li, Ning, Qian, Qijun

    Published in ChemistrySelect (Weinheim) (04-02-2021)
    “…Abstract Nucleic acid drugs were a class of DNA/RNA molecules and considered able to be applied for protein‐related diseases treatment through regulating…”
    Get full text
    Journal Article
  13. 13

    Scalable manufacturing methodologies for improving adeno-associated virus-based pharmaprojects by Xu Zenghui, Shi Chuanyin, Qian Qijun

    Published in Science bulletin (Beijing) (01-06-2014)
    “…Adeno-associated virus (AAV) is a promising viral vector and meets most requirements of being a safe biological agent. However, the commercialization of AAV…”
    Get full text
    Journal Article
  14. 14

    Safety and Efficacy of an Immune Cell-Specific Chimeric Promoter in Regulating Anti-PD-1 Antibody Expression in CAR T Cells by Fang, Yuan, Zhang, Yajun, Guo, Chuanxin, Chen, Chumeng, Gao, Haixia, Zhou, Xiumei, Liu, Tao, Qian, Qijun

    “…T cells modified to co-express cytokine or other factors with chimeric antigen receptor (CAR) can induce substantial and persistent increases in antitumor…”
    Get full text
    Journal Article
  15. 15

    Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells by Ding, Min, Li, Jiang, Yu, Yong, Liu, Hui, Yan, Zi, Wang, Jinghan, Qian, Qijun

    Published in Journal of translational medicine (11-08-2015)
    “…Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. HCC has a poor prognosis associated with tumor recurrence and drug resistance,…”
    Get full text
    Journal Article
  16. 16

    Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells by Jin, Huajun, Lv, Saiqun, Yang, Jiahe, Wang, Xiaoning, Hu, Huanzhang, Su, Changqing, Zhou, Chengliang, Li, Jiang, Huang, Yao, Li, Linfang, Liu, Xinyuan, Wu, Mengchao, Qian, Qijun

    Published in PloS one (21-07-2011)
    “…Highly selective therapy for hepatocellular carcinoma (HCC) remains an unmet medical need. In present study, we found that the tumor suppressor microRNA, let-7…”
    Get full text
    Journal Article
  17. 17
  18. 18

    P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells by Hu, Huanzhang, Li, Zhigang, Chen, Jie, Wang, Duanming, Ma, Juming, Wang, Weiguo, Li, Jiang, Wu, Hongping, Li, Linfang, Wu, Mengchao, Qian, Qijun, Chen, Jingbo, Su, Changqing

    Published in Gut (01-05-2011)
    “…Hepatocellular carcinoma (HCC) is one of the most malignant tumours with high rate of recurrence and metastasis. In HCC, deficiency of the P16/CDK4/Rb pathway…”
    Get more information
    Journal Article
  19. 19

    hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers by Ji, Weidan, Yang, Jiahe, Wang, Duanming, Cao, Lu, Tan, Weifeng, Qian, Haihua, Sun, Bin, Qian, Qijun, Yin, Zhengfeng, Wu, Mengchao, Su, Changqing

    Published in PloS one (10-08-2011)
    “…Human sulfatase 1 (hSulf-1) is a heparin-degrading endosulfatase that desulfates cell surface heparan sulfate proteoglycans (HSPGs) in extracellular matrix and…”
    Get full text
    Journal Article
  20. 20

    A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers by Wang, Xinghua, Su, Changqing, Cao, Hui, Li, Kui, Chen, Jie, Jiang, Lixin, Zhang, Qi, Wu, Xiaobing, Jia, Xiaoyuan, Liu, Yongjing, Wang, Weiguo, Liu, Xinyuan, Wu, Mengchao, Qian, Qijun

    Published in Molecular cancer therapeutics (01-06-2008)
    “…Conditionally replicating adenoviruses (CRAd) can replicate specifically in cancer cells and lyse them. The CRAds were widely used in the preclinical and…”
    Get full text
    Journal Article